Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Synsam ABCHIX:SYNSAS 85 Cash Ratio is 0.36 as of Mar. 2026, which is 38% above its 10-year median of 0.26. GuruFocus rates CHIX:SYNSAS with a GF Score™ of 85/100 and a GF Value™ of kr66.63. The stock has 1 warning sign investors should review. Among 837 Medical Devices & Instruments companies, Synsam AB ranks worse than 74.43% on this metric.
Synsam AB has a Cash Ratio of 0.36. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.
The historical rank and industry rank for Synsam AB's Cash Ratio or its related term are showing as below:
CHIX:SYNSAs'
s Cash Ratio Range Over the Past 10 Years
Min: 0.17 Med: 0.26 Max: 0.44
Current: 0.36
During the past 8 years, Synsam AB's highest Cash Ratio was 0.44. The lowest was 0.17. And the median was 0.26.
CHIX:SYNSAs's Cash Ratio is ranked worse than 74.43% of 837
companies
in the Medical Devices & Instruments industry
Industry Median: 0.95
vs CHIX:SYNSAs: 0.36
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Synsam AB Cash Ratio Related Terms
Synsam AB Cash Ratio Historical Data
* Premium members only.
The historical data trend for Synsam AB's Cash Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:SYNSAS vs ISRG, BDX, MDLN: Cash Ratio Comparison
For the Medical Instruments & Supplies subindustry, Synsam AB's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Synsam AB Cash Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Synsam AB's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Synsam AB's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Synsam AB (CHIX:SYNSAS) has a Cash Ratio of 0.36 as of Mar. 2026. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Synsam AB and its competitors. This is 38% above median its historical median of 0.26. Over the past decade, Synsam AB's Cash Ratio has ranged from 0.17 to 0.44. According to the industry distribution chart, Synsam AB ranks #623 out of 837 companies in the Medical Devices & Instruments industry, placing it in the top 74.4%.
Is Synsam AB's Cash Ratio too high?
Synsam AB's current Cash Ratio of 0.36 is 38% above median its 10-year median of 0.26. Over the past 10 years, this metric has ranged from a low of 0.17 to a high of 0.44. The Medical Devices & Instruments industry median Cash Ratio is 0.95. Synsam AB's value of 0.36 is 62.1% below this industry median. Based on the distribution chart, Synsam AB ranks #623 out of 837 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Synsam AB has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does Synsam AB's Cash Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Synsam AB ranks #623 out of 837 companies for Cash Ratio. This places Synsam AB in the lower half of its industry. The industry median Cash Ratio is 0.95. Synsam AB's value of 0.36 is 62.1% below this benchmark. Historically, Synsam AB's own Cash Ratio has ranged from 0.17 to 0.44 over the past decade. While the company's 10-year median is 0.26 vs. the industry median of 0.95, Synsam AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Medical Devices & Instruments company?
The median Cash Ratio among Medical Devices & Instruments companies is 0.95, based on 837 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Synsam AB's current Cash Ratio of 0.36 is 62.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Synsam AB and its competitors. For the Medical Devices & Instruments industry, the median Cash Ratio is 0.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Synsam AB's current Cash Ratio is 0.36, which is 38% above median its own 10-year median of 0.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synsam AB stock overvalued right now?
Synsam AB (CHIX:SYNSAS) has a current Cash Ratio of 0.36. The stock's GF Value™ is kr66.63, compared to a current price of kr59.80 — trading 10.3% below its estimated fair value. The current Cash Ratio is 0.36, which is 38% above median its 10-year median of 0.26 and 62.1% below the Medical Devices & Instruments industry median of 0.95. Synsam AB's overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Synsam AB (CHIX:SYNSAS), the current Cash Ratio is 0.36 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Synsam AB (CHIX:SYNSAS) Overvalued in 2026?
Based on GuruFocus' analysis, Synsam AB stock appears to be undervalued.
The current stock price of kr59.80 is trading 10.3% below its estimated GF Value™ of kr66.63.
Key valuation signals for CHIX:SYNSAS:
Cash Ratio: 0.36 (38% above median its 10-year median of 0.26)
GF Value™: kr66.63 vs. price of kr59.80 (10.3% below fair value)
Industry Position: 62.1% below the Medical Devices & Instruments median (#623 of 837)
No single metric tells the full story. See the CHIX:SYNSAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Synsam AB is a lifestyle company in optics and eye health in the Nordic region. The company offers various products and services in physical and digital stores, such as eye examinations, spectacles, sunglasses, sports spectacles, contact lenses, and accessories in optical retail, as well as spectacles subscriptions and related services under the name Synsam Lifestyle. Its stores are operated under the Synsam brand in Sweden, Norway, and Finland, and under the Profil Optik brand in Denmark and Iceland. The company comprises four segments: Sweden, which generates key revenue, Denmark, Norway, and Finland.
85GF Score
Get the complete analysis for CHIX:SYNSAS
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:SYNSAS has been successfully added to your 
